Industry News
'Overmanagement' Of Benign Breast Disease Revealed By Study
May 07, 2012
Contrary to current guidelines, women with benign breast biopsies do not need follow-up at six months; they may not need close surveillance at all, a new study shows. The study, conducted at Moffitt Cancer Center in Tampa, FL, followed 388 patients for six, 12 and 24 months. No cancer was found in these patients at six and 12 months, said Shannon Reed, MD, one of the authors of the study... Read More
'Overmanagement' Of Benign Breast Disease Revealed By Study
May 07, 2012
Contrary to current guidelines, women with benign breast biopsies do not need follow-up at six months; they may not need close surveillance at all, a new study shows. The study, conducted at Moffitt Cancer Center in Tampa, FL, followed 388 patients for six, 12 and 24 months. No cancer was found in these patients at six and 12 months, said Shannon Reed, MD, one of the authors of the study... Read More
Improving Hormone-Receptor-Positive Breast Cancer Management Through Progesterone Receptor Expression Measurement
May 07, 2012
American and Spanish researchers have found potential ways for doctors to improve the treatment of hormone receptor-positive breast cancer even if they lack access to costly multi-gene tests, as they reported at the 4th IMPAKT Breast Cancer Conference... Read More
Understanding Of Breast Cancer's Multiple Varieties Improved By New Data
May 07, 2012
New findings presented at Europe's leading breast cancer translational research conference this year shed new light on the many biological differences between individual breast cancers... Read More
Understanding Of Breast Cancer's Multiple Varieties Improved By New Data
May 07, 2012
New findings presented at Europe's leading breast cancer translational research conference this year shed new light on the many biological differences between individual breast cancers... Read More
"Spaghetti Models" Of Cancer Progression Built To Fight Cancer
May 06, 2012
Using mathematical models, researchers in the Integrated Mathematical Oncology (IMO) program at Moffitt Cancer Center are focusing their research on the interaction between the tumor and its microenvironment and the "selective forces" in that microenvironment that play a role in the growth and evolution of cancer. According to Alexander R. A. Anderson, Ph.D... Read More
Seeking Molecular Markers To Identify Breast Cancer Patients Who Would Benefit Most From Immune Suppressant
May 06, 2012
A new analysis may help doctors identify breast cancer patients who will benefit from treatment with the immune suppressant drug everolimus, say French researchers at the 4th IMPAKT Breast Cancer Conference in Brussels, Belgium. Everolimus is currently used as an immunosuppressant to prevent patients rejecting transplanted organs and in the treatment of renal cell cancer... Read More
Presentation At Breast Cancer Conference Reveals Breast Cancer In Young Women Is A Distinct Disease
May 06, 2012
Breast cancer in young women is a biologically unique disease that requires customized management strategies, researchers reported at the 4th IMPAKT Breast Cancer Conference, in Brussels, Belgium, 3-5 May 2012... Read More
Presentation At Breast Cancer Conference Reveals Breast Cancer In Young Women Is A Distinct Disease
May 06, 2012
Breast cancer in young women is a biologically unique disease that requires customized management strategies, researchers reported at the 4th IMPAKT Breast Cancer Conference, in Brussels, Belgium, 3-5 May 2012... Read More
Cancer-Causing Food Additives A Major Concern For Consumers
May 05, 2012
As with many concerned consumers, a team of University of Oklahoma researchers wondered if the green color sometimes seen in bacon is, in fact, harmful to human health. Recently, these OU scientists took an important first step in answering this question by determining the structure of the green pigment responsible for this 'nitrite burn... Read More
Previous Page Next Page